Page last updated: 2024-12-11

artepillin c

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

artepillin C: RN refers to (E)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5472440
CHEMBL ID456309
SCHEMBL ID1229229
MeSH IDM0267806

Synonyms (21)

Synonym
nsc-718732
nsc718732
artepillin c
(e)-3-[4-hydroxy-3,5-bis(3-methylbut-2-enyl)phenyl]prop-2-enoic acid
artepillin
CHEMBL456309
bdbm50362836
72944-19-5
3-(4-hydroxy-3,5-bis(3-methyl-2-butenyl)phenyl)-2-propenoic acid
2-propenoic acid, 3-(4-hydroxy-3,5-bis(3-methyl-2-butenyl)phenyl)-, (e)-
ccris 8746
gtpl6302
SCHEMBL1229229
Q27074514
(2e)-3-[4-hydroxy-3,5-bis(3-methylbut-2-en-1-yl)phenyl]prop-2-enoic acid
DTXSID201317933
AT37734
artepillinc
HY-N10319
CS-0379815
FS-6839

Research Excerpts

Overview

Artepillin C is a cinnamic acid derivative. It has been shown to have a wide variety of biological functions, including anti-inflammatory, antiviral and antitumor activities.

ExcerptReferenceRelevance
"Artepillin C is an important regulator of cytokine synthesis from activated spleen cells. "( Enhanced production of IL-2 from anti-CD3 antibody-stimulated mouse spleen cells by artepillin C, a major component of Brazilian green propolis.
Ando, M; Fujita, H; Ikeno, K; Kawaki, H; Kondoh, N; Mizuno-Kamiya, M; Nakamura, G; Nikaido, T; Takahashi, M; Takayama, E; Tsuruta, H; Ueno, K, 2022
)
2.39
"Artepillin C is an interesting compound due to its pharmacological properties, including antitumor activity."( Vibrational Spectroscopic Characterization and Coherent Anti-Stokes Raman Spectroscopy (CARS) Imaging of Artepillin C.
Brewer, JR; Constantino, CJL; Furini, LN; Jørgensen, B; Lemma, T; Pazin, WM; Rubira, RJG; Solovyeva, V, 2020
)
1.49
"Artepillin C is a cinnamic acid derivative and has been shown to have a wide variety of biological functions, including anti-inflammatory, antiviral and antitumor activities, in both cell culture and animal models."( Daily Brazilian green propolis intake elevates blood artepillin C levels in humans.
Ding, J; Hayakari, R; Imaizumi, T; Kawaguchi, S; Matsumiya, T; Seya, K; Shiba, Y; Ueno, K, 2021
)
1.59
"Artepillin C is a bioavailable antioxidant."( Antioxidative bioavailability of artepillin C in Brazilian propolis.
Ashida, H; Kanazawa, K; Matsuura, Y; Shimizu, K, 2004
)
1.33

Actions

ExcerptReferenceRelevance
"The artepillin C was found to cause significant damage to solid tumor and leukemic cells by the MTT assay, DNA synthesis assay, and morphological observation in vitro."( Apoptosis and suppression of tumor growth by artepillin C extracted from Brazilian propolis.
Aga, M; Arai, S; Kimoto, T; Kohguchi, M; Kurimoto, M; Micallef, MJ; Mito, K; Nomura, Y, 1998
)
1.04

Treatment

ExcerptReferenceRelevance
"Treatment with Artepillin C decreased prostaglandin E(2) by 29+/-3% and 58+/-5% at 1 and 10 mg/kg, respectively, with a mean ID(50) of 8.5 (8.0-8.7) mg/kg)."( Anti-inflammatory effects of a bioavailable compound, Artepillin C, in Brazilian propolis.
Abreu, SR; Bretz, WA; Dirsch, VM; Hori, H; Koyama, D; Nagasawa, H; Paulino, N; Scremin, A; Uto, Y; Vollmar, AM, 2008
)
0.93

Bioavailability

ExcerptReferenceRelevance
" The permeation of AC across Caco-2 cells is as efficient as that of phenolic acids and the microbial metabolites of poorly absorbed polyphenols, which are actively absorbed by the monocarboxylic acid transporter (MCT) (Biochim."( Absorption and bioavailability of artepillin C in rats after oral administration.
Hitomi, Y; Konishi, Y; Yoshida, M; Yoshioka, E, 2005
)
0.61
" Our aim in this study was to investigate the anti-inflammatory effects, absorption, and bioavailability of Artepillin C in mice."( Anti-inflammatory effects of a bioavailable compound, Artepillin C, in Brazilian propolis.
Abreu, SR; Bretz, WA; Dirsch, VM; Hori, H; Koyama, D; Nagasawa, H; Paulino, N; Scremin, A; Uto, Y; Vollmar, AM, 2008
)
0.81
" The good bioavailability by the oral route and good historical safety profile makes propolis an ideal adjuvant agent for future immunomodulatory or anticancer regimens."( The immunomodulatory and anticancer properties of propolis.
Chan, GC; Cheung, KW; Sze, DM, 2013
)
0.39
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (4)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Aldo-keto reductase family 1 member B10Homo sapiens (human)IC50 (µMol)53.00000.00101.94459.6000AID641086
Aldo-keto reductase family 1 member B1Homo sapiens (human)IC50 (µMol)23.00000.00101.191310.0000AID641085
Aldo-keto reductase family 1 member C3Homo sapiens (human)IC50 (µMol)1.00000.05002.207010.0000AID664542
Aldo-keto reductase family 1 member C3Homo sapiens (human)Ki0.68000.00590.70913.1000AID664551; AID664552
Serine/threonine-protein kinase PAK 1Homo sapiens (human)IC50 (µMol)25.00000.00020.30012.5000AID1424458
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (72)

Processvia Protein(s)Taxonomy
retinoid metabolic processAldo-keto reductase family 1 member B10Homo sapiens (human)
farnesol catabolic processAldo-keto reductase family 1 member B10Homo sapiens (human)
retinol metabolic processAldo-keto reductase family 1 member B10Homo sapiens (human)
daunorubicin metabolic processAldo-keto reductase family 1 member B10Homo sapiens (human)
doxorubicin metabolic processAldo-keto reductase family 1 member B10Homo sapiens (human)
cellular detoxification of aldehydeAldo-keto reductase family 1 member B10Homo sapiens (human)
retinoid metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
epithelial cell maturationAldo-keto reductase family 1 member B1Homo sapiens (human)
renal water homeostasisAldo-keto reductase family 1 member B1Homo sapiens (human)
carbohydrate metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
prostaglandin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
C21-steroid hormone biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
L-ascorbic acid biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
regulation of urine volumeAldo-keto reductase family 1 member B1Homo sapiens (human)
retinol metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
negative regulation of apoptotic processAldo-keto reductase family 1 member B1Homo sapiens (human)
daunorubicin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
doxorubicin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
fructose biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
cellular hyperosmotic salinity responseAldo-keto reductase family 1 member B1Homo sapiens (human)
metanephric collecting duct developmentAldo-keto reductase family 1 member B1Homo sapiens (human)
retinoid metabolic processAldo-keto reductase family 1 member C3Homo sapiens (human)
prostaglandin metabolic processAldo-keto reductase family 1 member C3Homo sapiens (human)
G protein-coupled receptor signaling pathwayAldo-keto reductase family 1 member C3Homo sapiens (human)
response to nutrientAldo-keto reductase family 1 member C3Homo sapiens (human)
steroid metabolic processAldo-keto reductase family 1 member C3Homo sapiens (human)
positive regulation of cell population proliferationAldo-keto reductase family 1 member C3Homo sapiens (human)
male gonad developmentAldo-keto reductase family 1 member C3Homo sapiens (human)
cellular response to starvationAldo-keto reductase family 1 member C3Homo sapiens (human)
farnesol catabolic processAldo-keto reductase family 1 member C3Homo sapiens (human)
cyclooxygenase pathwayAldo-keto reductase family 1 member C3Homo sapiens (human)
keratinocyte differentiationAldo-keto reductase family 1 member C3Homo sapiens (human)
progesterone metabolic processAldo-keto reductase family 1 member C3Homo sapiens (human)
retinol metabolic processAldo-keto reductase family 1 member C3Homo sapiens (human)
retinal metabolic processAldo-keto reductase family 1 member C3Homo sapiens (human)
macromolecule metabolic processAldo-keto reductase family 1 member C3Homo sapiens (human)
daunorubicin metabolic processAldo-keto reductase family 1 member C3Homo sapiens (human)
doxorubicin metabolic processAldo-keto reductase family 1 member C3Homo sapiens (human)
regulation of retinoic acid receptor signaling pathwayAldo-keto reductase family 1 member C3Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionAldo-keto reductase family 1 member C3Homo sapiens (human)
testosterone biosynthetic processAldo-keto reductase family 1 member C3Homo sapiens (human)
renal absorptionAldo-keto reductase family 1 member C3Homo sapiens (human)
cellular response to calcium ionAldo-keto reductase family 1 member C3Homo sapiens (human)
cellular response to prostaglandin stimulusAldo-keto reductase family 1 member C3Homo sapiens (human)
cellular response to corticosteroid stimulusAldo-keto reductase family 1 member C3Homo sapiens (human)
cellular response to jasmonic acid stimulusAldo-keto reductase family 1 member C3Homo sapiens (human)
cellular response to prostaglandin D stimulusAldo-keto reductase family 1 member C3Homo sapiens (human)
negative regulation of retinoic acid biosynthetic processAldo-keto reductase family 1 member C3Homo sapiens (human)
regulation of testosterone biosynthetic processAldo-keto reductase family 1 member C3Homo sapiens (human)
positive regulation of endothelial cell apoptotic processAldo-keto reductase family 1 member C3Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processAldo-keto reductase family 1 member C3Homo sapiens (human)
MAPK cascadeSerine/threonine-protein kinase PAK 1Homo sapiens (human)
cell migrationSerine/threonine-protein kinase PAK 1Homo sapiens (human)
actin cytoskeleton organizationSerine/threonine-protein kinase PAK 1Homo sapiens (human)
positive regulation of protein phosphorylationSerine/threonine-protein kinase PAK 1Homo sapiens (human)
stimulatory C-type lectin receptor signaling pathwaySerine/threonine-protein kinase PAK 1Homo sapiens (human)
chromatin remodelingSerine/threonine-protein kinase PAK 1Homo sapiens (human)
protein phosphorylationSerine/threonine-protein kinase PAK 1Homo sapiens (human)
exocytosisSerine/threonine-protein kinase PAK 1Homo sapiens (human)
apoptotic processSerine/threonine-protein kinase PAK 1Homo sapiens (human)
DNA damage responseSerine/threonine-protein kinase PAK 1Homo sapiens (human)
positive regulation of cell population proliferationSerine/threonine-protein kinase PAK 1Homo sapiens (human)
phosphorylationSerine/threonine-protein kinase PAK 1Homo sapiens (human)
actin cytoskeleton organizationSerine/threonine-protein kinase PAK 1Homo sapiens (human)
positive regulation of cell migrationSerine/threonine-protein kinase PAK 1Homo sapiens (human)
positive regulation of microtubule polymerizationSerine/threonine-protein kinase PAK 1Homo sapiens (human)
positive regulation of peptidyl-serine phosphorylationSerine/threonine-protein kinase PAK 1Homo sapiens (human)
positive regulation of intracellular estrogen receptor signaling pathwaySerine/threonine-protein kinase PAK 1Homo sapiens (human)
Fc-gamma receptor signaling pathway involved in phagocytosisSerine/threonine-protein kinase PAK 1Homo sapiens (human)
wound healingSerine/threonine-protein kinase PAK 1Homo sapiens (human)
positive regulation of JUN kinase activitySerine/threonine-protein kinase PAK 1Homo sapiens (human)
protein autophosphorylationSerine/threonine-protein kinase PAK 1Homo sapiens (human)
hepatocyte growth factor receptor signaling pathwaySerine/threonine-protein kinase PAK 1Homo sapiens (human)
ephrin receptor signaling pathwaySerine/threonine-protein kinase PAK 1Homo sapiens (human)
branching morphogenesis of an epithelial tubeSerine/threonine-protein kinase PAK 1Homo sapiens (human)
neuron projection morphogenesisSerine/threonine-protein kinase PAK 1Homo sapiens (human)
positive regulation of stress fiber assemblySerine/threonine-protein kinase PAK 1Homo sapiens (human)
negative regulation of cell proliferation involved in contact inhibitionSerine/threonine-protein kinase PAK 1Homo sapiens (human)
positive regulation of microtubule nucleationSerine/threonine-protein kinase PAK 1Homo sapiens (human)
protein localization to cytoplasmic stress granuleSerine/threonine-protein kinase PAK 1Homo sapiens (human)
intracellular signal transductionSerine/threonine-protein kinase PAK 1Homo sapiens (human)
regulation of actin cytoskeleton organizationSerine/threonine-protein kinase PAK 1Homo sapiens (human)
regulation of axonogenesisSerine/threonine-protein kinase PAK 1Homo sapiens (human)
regulation of MAPK cascadeSerine/threonine-protein kinase PAK 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (38)

Processvia Protein(s)Taxonomy
retinal dehydrogenase activityAldo-keto reductase family 1 member B10Homo sapiens (human)
aldo-keto reductase (NADPH) activityAldo-keto reductase family 1 member B10Homo sapiens (human)
protein bindingAldo-keto reductase family 1 member B10Homo sapiens (human)
alcohol dehydrogenase (NADP+) activityAldo-keto reductase family 1 member B10Homo sapiens (human)
geranylgeranyl reductase activityAldo-keto reductase family 1 member B10Homo sapiens (human)
allyl-alcohol dehydrogenase activityAldo-keto reductase family 1 member B10Homo sapiens (human)
indanol dehydrogenase activityAldo-keto reductase family 1 member B10Homo sapiens (human)
all-trans-retinol dehydrogenase (NADP+) activityAldo-keto reductase family 1 member B10Homo sapiens (human)
aldose reductase (NADPH) activityAldo-keto reductase family 1 member B10Homo sapiens (human)
retinal dehydrogenase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
aldose reductase (NADPH) activityAldo-keto reductase family 1 member B1Homo sapiens (human)
protein bindingAldo-keto reductase family 1 member B1Homo sapiens (human)
electron transfer activityAldo-keto reductase family 1 member B1Homo sapiens (human)
prostaglandin H2 endoperoxidase reductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
glyceraldehyde oxidoreductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
allyl-alcohol dehydrogenase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
L-glucuronate reductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
glycerol dehydrogenase [NADP+] activityAldo-keto reductase family 1 member B1Homo sapiens (human)
all-trans-retinol dehydrogenase (NADP+) activityAldo-keto reductase family 1 member B1Homo sapiens (human)
retinal dehydrogenase activityAldo-keto reductase family 1 member C3Homo sapiens (human)
aldose reductase (NADPH) activityAldo-keto reductase family 1 member C3Homo sapiens (human)
aldo-keto reductase (NADPH) activityAldo-keto reductase family 1 member C3Homo sapiens (human)
estradiol 17-beta-dehydrogenase [NAD(P)] activityAldo-keto reductase family 1 member C3Homo sapiens (human)
all-trans-retinol dehydrogenase (NAD+) activityAldo-keto reductase family 1 member C3Homo sapiens (human)
oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptorAldo-keto reductase family 1 member C3Homo sapiens (human)
phenanthrene 9,10-monooxygenase activityAldo-keto reductase family 1 member C3Homo sapiens (human)
dihydrotestosterone 17-beta-dehydrogenase activityAldo-keto reductase family 1 member C3Homo sapiens (human)
prostaglandin H2 endoperoxidase reductase activityAldo-keto reductase family 1 member C3Homo sapiens (human)
prostaglandin D2 11-ketoreductase activityAldo-keto reductase family 1 member C3Homo sapiens (human)
geranylgeranyl reductase activityAldo-keto reductase family 1 member C3Homo sapiens (human)
ketoreductase activityAldo-keto reductase family 1 member C3Homo sapiens (human)
prostaglandin-F synthase activityAldo-keto reductase family 1 member C3Homo sapiens (human)
15-hydroxyprostaglandin-D dehydrogenase (NADP+) activityAldo-keto reductase family 1 member C3Homo sapiens (human)
androsterone dehydrogenase activityAldo-keto reductase family 1 member C3Homo sapiens (human)
5alpha-androstane-3beta,17beta-diol dehydrogenase activityAldo-keto reductase family 1 member C3Homo sapiens (human)
testosterone dehydrogenase (NAD+) activityAldo-keto reductase family 1 member C3Homo sapiens (human)
androstan-3-alpha,17-beta-diol dehydrogenase activityAldo-keto reductase family 1 member C3Homo sapiens (human)
testosterone 17-beta-dehydrogenase (NADP+) activityAldo-keto reductase family 1 member C3Homo sapiens (human)
ketosteroid monooxygenase activityAldo-keto reductase family 1 member C3Homo sapiens (human)
Delta4-3-oxosteroid 5beta-reductase activityAldo-keto reductase family 1 member C3Homo sapiens (human)
all-trans-retinol dehydrogenase (NADP+) activityAldo-keto reductase family 1 member C3Homo sapiens (human)
bile acid bindingAldo-keto reductase family 1 member C3Homo sapiens (human)
small GTPase bindingSerine/threonine-protein kinase PAK 1Homo sapiens (human)
protein kinase activitySerine/threonine-protein kinase PAK 1Homo sapiens (human)
protein serine/threonine kinase activitySerine/threonine-protein kinase PAK 1Homo sapiens (human)
protein bindingSerine/threonine-protein kinase PAK 1Homo sapiens (human)
collagen bindingSerine/threonine-protein kinase PAK 1Homo sapiens (human)
ATP bindingSerine/threonine-protein kinase PAK 1Homo sapiens (human)
gamma-tubulin bindingSerine/threonine-protein kinase PAK 1Homo sapiens (human)
protein serine kinase activitySerine/threonine-protein kinase PAK 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (24)

Processvia Protein(s)Taxonomy
extracellular regionAldo-keto reductase family 1 member B10Homo sapiens (human)
lysosomeAldo-keto reductase family 1 member B10Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B10Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B10Homo sapiens (human)
mitochondrionAldo-keto reductase family 1 member B10Homo sapiens (human)
extracellular spaceAldo-keto reductase family 1 member B1Homo sapiens (human)
nucleoplasmAldo-keto reductase family 1 member B1Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B1Homo sapiens (human)
extracellular exosomeAldo-keto reductase family 1 member B1Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B1Homo sapiens (human)
nucleusAldo-keto reductase family 1 member C3Homo sapiens (human)
cytoplasmAldo-keto reductase family 1 member C3Homo sapiens (human)
cytosolAldo-keto reductase family 1 member C3Homo sapiens (human)
extracellular exosomeAldo-keto reductase family 1 member C3Homo sapiens (human)
cytosolAldo-keto reductase family 1 member C3Homo sapiens (human)
ruffleSerine/threonine-protein kinase PAK 1Homo sapiens (human)
nucleoplasmSerine/threonine-protein kinase PAK 1Homo sapiens (human)
chromosomeSerine/threonine-protein kinase PAK 1Homo sapiens (human)
cytoplasmSerine/threonine-protein kinase PAK 1Homo sapiens (human)
centrosomeSerine/threonine-protein kinase PAK 1Homo sapiens (human)
cytosolSerine/threonine-protein kinase PAK 1Homo sapiens (human)
actin filamentSerine/threonine-protein kinase PAK 1Homo sapiens (human)
plasma membraneSerine/threonine-protein kinase PAK 1Homo sapiens (human)
cell-cell junctionSerine/threonine-protein kinase PAK 1Homo sapiens (human)
focal adhesionSerine/threonine-protein kinase PAK 1Homo sapiens (human)
intercalated discSerine/threonine-protein kinase PAK 1Homo sapiens (human)
Z discSerine/threonine-protein kinase PAK 1Homo sapiens (human)
lamellipodiumSerine/threonine-protein kinase PAK 1Homo sapiens (human)
axonSerine/threonine-protein kinase PAK 1Homo sapiens (human)
dendriteSerine/threonine-protein kinase PAK 1Homo sapiens (human)
nuclear membraneSerine/threonine-protein kinase PAK 1Homo sapiens (human)
ruffle membraneSerine/threonine-protein kinase PAK 1Homo sapiens (human)
protein-containing complexSerine/threonine-protein kinase PAK 1Homo sapiens (human)
cytoplasmSerine/threonine-protein kinase PAK 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (29)

Assay IDTitleYearJournalArticle
AID664551Competitive inhibition of human recombinant AKR1C3 expressed in Escherichia coli JM109 cells using S-tetralol as substrate by fluorometry2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Selective inhibition of human type-5 17β-hydroxysteroid dehydrogenase (AKR1C3) by baccharin, a component of Brazilian propolis.
AID1752498Cytotoxicity against human MCF-10A cells assessed as cell viability for 72 hrs by MTT assay2021Bioorganic & medicinal chemistry, 10-01, Volume: 47Synthesis, antitumor activity and in silico analyses of amino acid derivatives of artepillin C, drupanin and baccharin from green propolis.
AID1424460Growth inhibition of human A549 cells2017European journal of medicinal chemistry, Dec-15, Volume: 142From bench (laboratory) to bed (hospital/home): How to explore effective natural and synthetic PAK1-blockers/longevity-promoters for cancer therapy.
AID664547Inhibition of human recombinant GST-tagged AKR1C4 expressed in Escherichia coli using S-tetralol as substrate at 100 uM by fluorometry2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Selective inhibition of human type-5 17β-hydroxysteroid dehydrogenase (AKR1C3) by baccharin, a component of Brazilian propolis.
AID1424459Growth stimulation of HFDPC assessed as increase in cell viability incubated for 3 days by MTT assay2017European journal of medicinal chemistry, Dec-15, Volume: 142From bench (laboratory) to bed (hospital/home): How to explore effective natural and synthetic PAK1-blockers/longevity-promoters for cancer therapy.
AID1752502Selectivity index, ratio of CC50 for human PNT2 cells to IC50 for human DU-145 cells2021Bioorganic & medicinal chemistry, 10-01, Volume: 47Synthesis, antitumor activity and in silico analyses of amino acid derivatives of artepillin C, drupanin and baccharin from green propolis.
AID641086Inhibition of human recombinant N-terminus His6-tagged AKR1B10 expressed in Escherichia coli BL21 DE3 assessed as pyridine-3-aldehyde reduction by spectrometric analysis2012European journal of medicinal chemistry, Feb, Volume: 48Design, synthesis and evaluation of caffeic acid phenethyl ester-based inhibitors targeting a selectivity pocket in the active site of human aldo-keto reductase 1B10.
AID614379Cytotoxicity against human HCT116 cells assessed as cell viability under normoxic condition at 200 uM after 24 hrs by MTT assay2011Bioorganic & medicinal chemistry, Sep-15, Volume: 19, Issue:18
Isolation, identification, and biological evaluation of HIF-1-modulating compounds from Brazilian green propolis.
AID1752500Antiproliferative activity against human DU-145 cells assessed as cell viability for 72 hrs by MTT assay2021Bioorganic & medicinal chemistry, 10-01, Volume: 47Synthesis, antitumor activity and in silico analyses of amino acid derivatives of artepillin C, drupanin and baccharin from green propolis.
AID1752496Selectivity index, ratio of CC50 for human MCF-10A cells and IC50 for human MCF7 cells2021Bioorganic & medicinal chemistry, 10-01, Volume: 47Synthesis, antitumor activity and in silico analyses of amino acid derivatives of artepillin C, drupanin and baccharin from green propolis.
AID404063Cytotoxicity against human HT1080 cells after 24 hrs by MTT assay1998Journal of natural products, Jul, Volume: 61, Issue:7
Chemical constituents of Brazilian propolis and their cytotoxic activities.
AID664544Inhibition of human recombinant GST-tagged AKR1C1 expressed in Escherichia coli using S-tetralol as substrate at 100 uM by fluorometry2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Selective inhibition of human type-5 17β-hydroxysteroid dehydrogenase (AKR1C3) by baccharin, a component of Brazilian propolis.
AID1424458Inhibition of PAK1 (unknown origin) by cell culture based assay2017European journal of medicinal chemistry, Dec-15, Volume: 142From bench (laboratory) to bed (hospital/home): How to explore effective natural and synthetic PAK1-blockers/longevity-promoters for cancer therapy.
AID1752501Selectivity index, ratio of CC50 for human PNT2 cells to IC50 for human PC-3 cells2021Bioorganic & medicinal chemistry, 10-01, Volume: 47Synthesis, antitumor activity and in silico analyses of amino acid derivatives of artepillin C, drupanin and baccharin from green propolis.
AID641085Inhibition of human recombinant N-terminus His6-tagged AKR1B1 expressed in Escherichia coli BL21 DE3 assessed as pyridine-3-aldehyde reduction by spectrometric analysis2012European journal of medicinal chemistry, Feb, Volume: 48Design, synthesis and evaluation of caffeic acid phenethyl ester-based inhibitors targeting a selectivity pocket in the active site of human aldo-keto reductase 1B10.
AID1752495Antiproliferative activity against human MDA-MB-231 cells assessed as cell viability for 72 hrs by MTT assay2021Bioorganic & medicinal chemistry, 10-01, Volume: 47Synthesis, antitumor activity and in silico analyses of amino acid derivatives of artepillin C, drupanin and baccharin from green propolis.
AID664552Noncompetitive inhibition of human recombinant AKR1C3 expressed in Escherichia coli JM109 cells using S-tetralol as substrate by fluorometry in presence of NADP+2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Selective inhibition of human type-5 17β-hydroxysteroid dehydrogenase (AKR1C3) by baccharin, a component of Brazilian propolis.
AID664561Cytotoxicity against human MCF7 cells at <100 uM after 6 hrs by MTT assay2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Selective inhibition of human type-5 17β-hydroxysteroid dehydrogenase (AKR1C3) by baccharin, a component of Brazilian propolis.
AID404064Cytotoxicity against mouse 26-L5 cells after 24 hrs by MTT assay1998Journal of natural products, Jul, Volume: 61, Issue:7
Chemical constituents of Brazilian propolis and their cytotoxic activities.
AID1752497Selectivity index, ratio of CC50 for human MCF-10A cells and IC50 for human MDA-MB-231 cells2021Bioorganic & medicinal chemistry, 10-01, Volume: 47Synthesis, antitumor activity and in silico analyses of amino acid derivatives of artepillin C, drupanin and baccharin from green propolis.
AID614378Modulation of HIF1 expressed in HEK293 cells assessed as luciferase activity under hypoxic condition at 50 uM after 24 hrs by luminometer analysis relative to hypoxic control2011Bioorganic & medicinal chemistry, Sep-15, Volume: 19, Issue:18
Isolation, identification, and biological evaluation of HIF-1-modulating compounds from Brazilian green propolis.
AID1752503Cytotoxicity against human PNT2 cells assessed as cell viability for 72 hrs by MTT assay2021Bioorganic & medicinal chemistry, 10-01, Volume: 47Synthesis, antitumor activity and in silico analyses of amino acid derivatives of artepillin C, drupanin and baccharin from green propolis.
AID664542Inhibition of human recombinant AKR1C3 expressed in Escherichia coli JM109 cells using S-tetralol as substrate by fluorometry2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Selective inhibition of human type-5 17β-hydroxysteroid dehydrogenase (AKR1C3) by baccharin, a component of Brazilian propolis.
AID1752499Antiproliferative activity against human PC-3 cells assessed as cell viability for 72 hrs by MTT assay2021Bioorganic & medicinal chemistry, 10-01, Volume: 47Synthesis, antitumor activity and in silico analyses of amino acid derivatives of artepillin C, drupanin and baccharin from green propolis.
AID664545Inhibition of human recombinant AKR1C2 expressed in Escherichia coli using S-tetralol as substrate at 100 uM by fluorometry2012Journal of natural products, Apr-27, Volume: 75, Issue:4
Selective inhibition of human type-5 17β-hydroxysteroid dehydrogenase (AKR1C3) by baccharin, a component of Brazilian propolis.
AID614438Antiangiogenic activity in 3-day-old embryonated chicken eggs at 300 ng/CAM measured on 7th embryonic day by CAM assay2011Bioorganic & medicinal chemistry, Sep-15, Volume: 19, Issue:18
Isolation, identification, and biological evaluation of HIF-1-modulating compounds from Brazilian green propolis.
AID1752494Antiproliferative activity against human MCF7 cells assessed as cell viability for 72 hrs by MTT assay2021Bioorganic & medicinal chemistry, 10-01, Volume: 47Synthesis, antitumor activity and in silico analyses of amino acid derivatives of artepillin C, drupanin and baccharin from green propolis.
AID456268Antiallergic activity in Ca(2+)-stimulated differentiated human HeLa cells assessed as inhibition of cys-leukotriene release after 6 days by ELISA2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Inhibitory activity of Brazilian green propolis components and their derivatives on the release of cys-leukotrienes.
AID1346556Human TRPA1 (Transient Receptor Potential channels)2012PloS one, , Volume: 7, Issue:11
Artepillin C, a major ingredient of Brazilian propolis, induces a pungent taste by activating TRPA1 channels.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (84)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (3.57)18.2507
2000's19 (22.62)29.6817
2010's44 (52.38)24.3611
2020's18 (21.43)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.10

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.10 (24.57)
Research Supply Index4.51 (2.92)
Research Growth Index5.26 (4.65)
Search Engine Demand Index62.09 (26.88)
Search Engine Supply Index3.92 (0.95)

This Compound (28.10)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (2.27%)5.53%
Reviews5 (5.68%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other81 (92.05%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]